Pharmaceutical Science Advances, a journal from Shandong University, publishes peer-reviewed research across all fields of pharmaceutical science.
Jinan, Shandong, CHINA
Joined April 2023
- Tweets289
- Following60
- Followers588
- Likes124
Pharmaceutical Science Advances retweeted
Highlight✍️#Protein #degradation-based #anti-#infective #drug research. From Dr. Zhan @ShandongUniversity;
sciencedirect.com/science/ar….
Pharmaceutical Science Advances retweeted
After 60 years, scientists finally know why ginger, calico, and tortoiseshell #cats look the way they do. bit.ly/4eTU84K @NewsfromScience
Pharmaceutical Science Advances retweeted
The promise of a personalized (neoantigen) vaccine for treating cancer, as seen by immune response bolstering against renal cell carcinoma in a Phase 1 trial
nature.com/articles/s41586-0…
nature.com/articles/d41586-0… @DrChoueiri @Nature
Pharmaceutical Science Advances retweeted
#Parkinsonsdisease and other #synucleinopathies are undergoing a paradigm shift towards being defined and staged by biology, rather than symptoms; our latest Perspective offers context on progress, needs & opportunities
@McGovernMed @pddoc @Proteopathy_Lab
nature.com/articles/s41591-0…
Pharmaceutical Science Advances retweeted
A new generation of cancer-preventing vaccines could wipe out tumors before they form.
Learn more on #WorldCancerDay: scim.ag/8o0 @NewsfromScience
Pharmaceutical Science Advances retweeted
People with vitiligo develop skin depigmentation that can now be reversed with treatment.
In this review, @HarrisVitiligo et al. @UMassChan suggest that recent advances in treating vitiligo open new avenues for studying other mechanisms in autoimmune diseases.
Pharmaceutical Science Advances retweeted
For readers interested in drug development for psychiatric disorders, this Perspective discusses approaches to reducing failure rates in late-stage clinical trials
nature.com/articles/s41573-0…
rdcu.be/d56k3
Pharmaceutical Science Advances retweeted
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function dlvr.it/THLx62
Pharmaceutical Science Advances retweeted
Antibiotics in endodontics: A survey using questionnaires to determine the frequency of antibiotics prescription by dentists in Saudi Arabia
Read the Article here: bit.ly/4iTsZ5d
#Allergy #AcuteRheumaticFever #Duration #EndodonticSurgeries #Resistance #Biomedical
Pharmaceutical Science Advances retweeted
A single-cell transcriptomic study from the Human Cell Atlas integrating over 11 million brain cells from 70 studies uncovers differences across human brain regions and identifies new progenitor and microglia subtypes
nature.com/articles/s41591-0…
Pharmaceutical Science Advances retweeted
Wen et al. utilize a solid phase reaction to prepare an #amorphous (#lysine)2PbI2 layer to neutralize surface and interface defects, achieving #device #efficiency of over 26% for #perovskite #solarcells #photovoltaics #GettingApplied nature.com/articles/s41467-0…
Pharmaceutical Science Advances retweeted
When playing the NK cell therapy card in glioblastoma, you can’t beat interleukin-21 dlvr.it/TC0rdV
Pharmaceutical Science Advances retweeted
Transcription factor dependencies identify BAF-dependent cancers dlvr.it/TBtQQf
Pharmaceutical Science Advances retweeted
Puff, the polytene chromosome: Visualizing transcription elongation control dlvr.it/TBqRGQ
Pharmaceutical Science Advances retweeted
Analyses of tumour and bone marrow tissue from patients with glioblastoma demonstrates the presence of extracerebral niches that contained tumor-reactive and memory T cell subsets. nature.com/articles/s41591-0…
Pharmaceutical Science Advances retweeted
Trained on 1.5 million WSIs from 100,000 patients, a pathology foundation model is shown to improve performance of specialized models in detection of rare cancers @paige_ai @MSFTResearch #DigitalPathology #FoundationModel
nature.com/articles/s41591-0…
Pharmaceutical Science Advances retweeted
Letter to Editor✍️Discovery and characterization of novel potent non-#covalent small molecule #inhibitors targeting #papain-#like #protease from #SARS-CoV-2. From Dr. Zhou @ShenyangPharmaceuticalUniversity;
sciencedirect.com/science/ar….
Pharmaceutical Science Advances retweeted
FDA approves third anti-amyloid antibody for Alzheimer disease bit.ly/3WaNReT
Eli Lilly’s donanemab (Kisunla) is now approved for early symptomatic Alzheimer disease.
Pharmaceutical Science Advances retweeted
Chinese innovative drug R&D trends in 2024 bit.ly/3ykX8YK
This new article analyses trends for the innovative drug candidates in the pipelines of Chinese companies
Pharmaceutical Science Advances retweeted
Our latest research highlight covers two Nature papers on a molecular-glue-based RAS inhibitor that has activity in preclinical models of pancreatic cancer bit.ly/4buWJRx
For more on progress in targeting RAS, here's a news story from last year bit.ly/4dtlWO5
